The global medical plastics market was valued at approximately USD 52.9 billion in 2023, and it is projected to expand at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2030. This robust growth is largely due to the development of innovative plastics and plastic composites tailored for medical applications, such as components in catheters, surgical instrument handles, and syringes. There is a notable increase in demand for advanced medical device packaging, driven by the rising need for sophisticated, in-house medical devices. Key plastics like polyethylene, polypropylene, and polycarbonate are gaining popularity in manufacturing a variety of medical devices. The expansion of home healthcare services, due to their cost-effectiveness relative to traditional hospital and intensive care, has led to increased demand for medical devices, further fueling market growth.

The medical plastics market is in a high-growth phase, and the growth pace is accelerating due to its consolidated nature. Manufacturers of medical plastics are actively adopting strategic initiatives such as mergers, acquisitions, product innovations, and expansions in production capacity. For example, in November 2023, TekniPlex Healthcare acquired Seisa Medical, an El Paso-based medical device manufacturer. This acquisition is expected to enhance TekniPlex’s global capabilities in materials science and process technologies, particularly for devices used in interventional therapies and minimally invasive procedures. Seisa offers comprehensive contract manufacturing services for Class II and III medical devices, covering development, design, component manufacturing, assembly, and packaging.

Gather more insights about the market drivers, restrains and growth of the Medical Plastics Market

Regional Insights:

In 2023, North America held the leading position in the global medical plastics market, accounting for over 33.0% of the market share. This strong position is expected to fuel demand for both generic drugs and medical devices, supporting further market expansion in North America. The medical plastics industry primarily serves applications such as pharmaceutical packaging and medical component manufacturing. The growth in medical plastics demand in North America is also supported by the expanding pharmaceutical industry in Mexico and Canada, along with increasing demand in pharmaceutical packaging applications.

For instance, the Mexican government’s recent relaxation of regulatory restrictions, which previously limited new manufacturing operations, has enabled pharmaceutical giants like Takeda and Astellas to establish manufacturing facilities in Mexico. This strategic shift has strengthened the domestic pharmaceutical industry, which is expected to drive demand for medical plastics in the coming years. Key applications analyzed for the North American market include medical device packaging, medical components, wound care products, mobility aids, and dental implants. Furthermore, the region has seen a rise in healthcare spending due to increasing cases of lifestyle-related diseases such as diabetes and cardiovascular disorders. This trend is expected to stimulate demand for medical devices, generic drugs, and healthcare services, thereby supporting the growth of the medical plastics market.

Additionally, the region’s growing elderly population and the increasing incidence of chronic diseases are projected to drive demand for medical devices, further increasing the use of plastics in manufacturing medical equipment over the forecast period. Government investment in the healthcare sector and the rise of the home healthcare market are expected to amplify demand for medical devices, positively influencing the medical plastics market.

Browse through Grand View Research's Category Plastics, Polymers & Resins Industry Research Reports.

  • The global flexitank market size was estimated at USD 1,357.3 million in 2024 and is projected to grow at a CAGR of 23.6% from 2025 to 2030.
  • The global elastomer gel in personal care market size was valued at USD 160.5 million in 2024 and is anticipated to grow at a CAGR of 4.1% from 2025 to 2030.

Key Companies & Market Share Insights:

Prominent players in the medical plastics market include BASF SE, Celanese Corporation, Evonik Industries AG, SABIC, Dow Inc., Solvay S.A., Trinseo S.A., and Eastman Chemical Company. In November 2022, Celanese Corporation completed the acquisition of DuPont's Mobility & Materials (M&M) division for USD 11 billion. This acquisition expands Celanese’s global market presence and enhances its capabilities, especially in sustainable transportation solutions, by adding environmentally focused product offerings to its portfolio.

Key Medical Plastics Companies:

  • Röchling SE & Co. KG
  • Nolato AB
  • Saint-Gobain
  • SABIC
  • Orthoplastics Ltd
  • Eastman Chemical Company
  • Celanese Corporation
  • Dow, Inc.
  • Tekni-Plex, Inc.
  • Solvay S.A.
  • HMC Polymers Company Limited
  • ARAN BIOMEDICAL TEORANTA
  • Trelleborg Group
  • Avantor, Inc.
  • Trinseo
  • Evonik Industries AG

Order a free sample PDF of the Medical Plastics Market Intelligence Study, published by Grand View Research.